Pro Medicus Ownership

PME Stock   268.64  0.25  0.09%   
Pro Medicus owns a total of 104.5 Million outstanding shares. Pro Medicus has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
1998-12-31
Previous Quarter
104.7 M
Current Value
104.6 M
Avarage Shares Outstanding
101.5 M
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Dividends Paid is likely to gain to about 44.1 M in 2025. Net Income Applicable To Common Shares is likely to gain to about 73.2 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 111.9 M in 2025.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pro Stock Ownership Analysis

About 49.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 4th of September 2024. To find out more about Pro Medicus contact MD MBBS at 61 3 9429 8800 or learn more at https://www.promed.com.au.

Pro Medicus Outstanding Bonds

Pro Medicus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pro Medicus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pro bonds can be classified according to their maturity, which is the date when Pro Medicus has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pro Stock Analysis

When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.